Valeant Securities Suit Was Launched On Time, 3rd Circ. Told
Investors in Valeant Pharmaceuticals Inc. urged the Third Circuit to revive their claims that the company engaged in a price-gouging scheme that cost stockholders billions, arguing Tuesday that a lower court...To view the full article, register now.
Already a subscriber? Click here to view full article